Barrington Research Maintains Outperform on Imax, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst James Goss maintains an Outperform rating on Imax (NYSE:IMAX) and keeps the price target at $24.
April 22, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research reaffirms an Outperform rating on Imax, with a steady price target of $24.
The reaffirmation of the Outperform rating and the maintenance of the $24 price target by Barrington Research suggests a positive outlook for Imax's stock. This endorsement from a reputable analyst could lead to increased investor confidence in Imax, potentially driving up its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100